OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Neuroprotective Effects of a Cholecystokinin Analogue in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Parkinson’s Disease Mouse Model
Zijuan Zhang, Hai Li, Yunfang Su, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 18
Zijuan Zhang, Hai Li, Yunfang Su, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 18
Showing 18 citing articles:
Cholecystokinin (CCK): a neuromodulator with therapeutic potential in Alzheimer’s and Parkinson’s disease
Niklas Reich, Christian Hölscher
Frontiers in Neuroendocrinology (2024) Vol. 73, pp. 101122-101122
Open Access | Times Cited: 16
Niklas Reich, Christian Hölscher
Frontiers in Neuroendocrinology (2024) Vol. 73, pp. 101122-101122
Open Access | Times Cited: 16
Bile acids and neurological disease
Michael J. Hurley, Rachel Bates, Jane Macnaughtan, et al.
Pharmacology & Therapeutics (2022) Vol. 240, pp. 108311-108311
Open Access | Times Cited: 43
Michael J. Hurley, Rachel Bates, Jane Macnaughtan, et al.
Pharmacology & Therapeutics (2022) Vol. 240, pp. 108311-108311
Open Access | Times Cited: 43
Bile acid metabolism in health and ageing-related diseases
Xiaojun Li, Chu Fang, Ruihua Zhao, et al.
Biochemical Pharmacology (2024) Vol. 225, pp. 116313-116313
Closed Access | Times Cited: 7
Xiaojun Li, Chu Fang, Ruihua Zhao, et al.
Biochemical Pharmacology (2024) Vol. 225, pp. 116313-116313
Closed Access | Times Cited: 7
cAMP-PKA signaling pathway and anxiety: Where do we go next?
Daokang Chen, Jingji Wang, Jian Cao, et al.
Cellular Signalling (2024) Vol. 122, pp. 111311-111311
Closed Access | Times Cited: 7
Daokang Chen, Jingji Wang, Jian Cao, et al.
Cellular Signalling (2024) Vol. 122, pp. 111311-111311
Closed Access | Times Cited: 7
Cholecystokinin and glucagon-like peptide-1 analogues regulate intestinal tight junction, inflammation, dopaminergic neurons and α-synuclein accumulation in the colon of two Parkinson's disease mouse models
Yunfang Su, Ningning Liu, Zijuan Zhang, et al.
European Journal of Pharmacology (2022) Vol. 926, pp. 175029-175029
Closed Access | Times Cited: 24
Yunfang Su, Ningning Liu, Zijuan Zhang, et al.
European Journal of Pharmacology (2022) Vol. 926, pp. 175029-175029
Closed Access | Times Cited: 24
Radix Rehmanniae Praeparata (Shu Dihuang) exerts neuroprotective effects on ICV-STZ-induced Alzheimer’s disease mice through modulation of INSR/IRS-1/AKT/GSK-3β signaling pathway and intestinal microbiota
Yunfang Su, Ningning Liu, Ruiqin Sun, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 14
Yunfang Su, Ningning Liu, Ruiqin Sun, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 14
Cholecystokinin Signaling can Rescue Cognition and Synaptic Plasticity in the APP/PS1 Mouse Model of Alzheimer’s Disease
Zijuan Zhang, Ziyang Yu, Ye Yuan, et al.
Molecular Neurobiology (2023) Vol. 60, Iss. 9, pp. 5067-5089
Closed Access | Times Cited: 13
Zijuan Zhang, Ziyang Yu, Ye Yuan, et al.
Molecular Neurobiology (2023) Vol. 60, Iss. 9, pp. 5067-5089
Closed Access | Times Cited: 13
Advances in fucoxanthin chemistry and management of neurodegenerative diseases
Na Li, Xiaoxiang Gao, Lingjun Zheng, et al.
Phytomedicine (2022) Vol. 105, pp. 154352-154352
Closed Access | Times Cited: 22
Na Li, Xiaoxiang Gao, Lingjun Zheng, et al.
Phytomedicine (2022) Vol. 105, pp. 154352-154352
Closed Access | Times Cited: 22
Local and long-range GABAergic circuits in hippocampal area CA1 and their link to Alzheimer’s disease
Melissa Hernández‐Frausto, Olesia M. Bilash, Arjun V. Masurkar, et al.
Frontiers in Neural Circuits (2023) Vol. 17
Open Access | Times Cited: 12
Melissa Hernández‐Frausto, Olesia M. Bilash, Arjun V. Masurkar, et al.
Frontiers in Neural Circuits (2023) Vol. 17
Open Access | Times Cited: 12
The neuroprotective effects of cholecystokinin in the brain: antioxidant, anti-inflammatory, cognition, and synaptic plasticity
Hailiang Cui, Zhonghua Li, Hongyu Sun, et al.
Reviews in the Neurosciences (2025)
Closed Access
Hailiang Cui, Zhonghua Li, Hongyu Sun, et al.
Reviews in the Neurosciences (2025)
Closed Access
Probiotics reverse gut dysbiosis and memory impairment associated with esomeprazole use in chronically stressed rats: A significant neuroprotective role for cholecystokinin
Reem M Eladawy, Lamiaa A. Ahmed, Maha B. Salem, et al.
International Immunopharmacology (2025) Vol. 150, pp. 114227-114227
Closed Access
Reem M Eladawy, Lamiaa A. Ahmed, Maha B. Salem, et al.
International Immunopharmacology (2025) Vol. 150, pp. 114227-114227
Closed Access
Brucella suis S2 strain inhibits IRE1/caspase-12/caspase-3 pathway-mediated apoptosis of microglia HMC3 by affecting the ubiquitination of CALR
Zhao Wang, Yanbai Wang, Shu‐Long Yang, et al.
mSphere (2025)
Open Access
Zhao Wang, Yanbai Wang, Shu‐Long Yang, et al.
mSphere (2025)
Open Access
A novel Dual GLP-1/CCK Receptor Agonist Improves Cognitive Performance and Synaptogenesis in the 5 × FAD Alzheimer Mouse Model
He Ma, Zengyi Chang, Hongyu Sun, et al.
Molecular Neurobiology (2025)
Closed Access
He Ma, Zengyi Chang, Hongyu Sun, et al.
Molecular Neurobiology (2025)
Closed Access
Psychosis in Parkinson’s Disease: A Lesson from Genetics
Efthalia Angelopoulou, Anastasia Bougea, Sokratis G. Papageorgiou, et al.
Genes (2022) Vol. 13, Iss. 6, pp. 1099-1099
Open Access | Times Cited: 15
Efthalia Angelopoulou, Anastasia Bougea, Sokratis G. Papageorgiou, et al.
Genes (2022) Vol. 13, Iss. 6, pp. 1099-1099
Open Access | Times Cited: 15
A Dual GLP-1/GIP Receptor Agonist Is More Effective than Liraglutide in the A53T Mouse Model of Parkinson’s Disease
Zijuan Zhang, Ming Shi, Zhengmin Li, et al.
Parkinson s Disease (2023) Vol. 2023, pp. 1-13
Open Access | Times Cited: 9
Zijuan Zhang, Ming Shi, Zhengmin Li, et al.
Parkinson s Disease (2023) Vol. 2023, pp. 1-13
Open Access | Times Cited: 9
Several neuropeptides involved in parkinsonian neuroprotection modulate the firing properties of nigral dopaminergic neurons
Lei Chen, Cui Liu, Yan Xue, et al.
Neuropeptides (2023) Vol. 99, pp. 102337-102337
Closed Access | Times Cited: 8
Lei Chen, Cui Liu, Yan Xue, et al.
Neuropeptides (2023) Vol. 99, pp. 102337-102337
Closed Access | Times Cited: 8
New Insights on the Role of Bioactive Food Derivatives in Neurodegeneration and Neuroprotection
Alexandre Fisette, Domenico Sergi, Alyssa Breton-Morin, et al.
Current Pharmaceutical Design (2022) Vol. 28, Iss. 37, pp. 3068-3081
Closed Access | Times Cited: 5
Alexandre Fisette, Domenico Sergi, Alyssa Breton-Morin, et al.
Current Pharmaceutical Design (2022) Vol. 28, Iss. 37, pp. 3068-3081
Closed Access | Times Cited: 5
GW9508 ameliorates cognitive dysfunction via autophagy pathway in streptozotocin‐induced mouse model of Alzheimer's disease
Yanan Wang, Jingjing Chen, Chen Wang, et al.
Fundamental and Clinical Pharmacology (2024) Vol. 38, Iss. 5, pp. 906-923
Closed Access
Yanan Wang, Jingjing Chen, Chen Wang, et al.
Fundamental and Clinical Pharmacology (2024) Vol. 38, Iss. 5, pp. 906-923
Closed Access
Novel insights into Cntnap4 in Alzheimer's disease: Intestinal flora interaction
Xiaodan Xiao, Yanfei Guan, Heejung Mo, et al.
International Journal of Biological Macromolecules (2024), pp. 138508-138508
Closed Access
Xiaodan Xiao, Yanfei Guan, Heejung Mo, et al.
International Journal of Biological Macromolecules (2024), pp. 138508-138508
Closed Access
